| Literature DB >> 26875838 |
Qinwei Sun1, Xi Li, Yimin Jia, Shifeng Pan, Runsheng Li, Xiaojing Yang, Ruqian Zhao.
Abstract
Methyl donor nutrients are critical for embryonic development of brain. Hippocampus is the most susceptible brain region to various factors including prenatal supply of methyl donors. Glucocorticoid receptor (GR) expressed in hippocampus is involved in the regulation of energy homeostasis and stress sensitivity. Hippocampal GR expression is highly susceptible to epigenetic regulation, yet the effect of maternal methyl donor supplementation on epigenetic regulation of GR transcription in offspring hippocampus remains unclear. In this study, we fed sows with betaine (3 g/kg) throughout the gestation and analyzed the hippocampal expression of GR mRNA and its variants, as well as the CpG methylation status of the promoter and the microRNAs predicted to target 3' UTR of porcine GR gene in neonatal piglets. Total GR mRNA (P<0.01) and its variants GR 1-4 (P<0.05) and 1-9,10 (P<0.01), were significantly higher in the hippocampus of betaine-treated piglets, while the content of GR protein was not significantly changed. The CpGs located in the -1650 ~ -1515 segment of GR gene were hypermethylated (P<0.05). The hippocampal expression of miR-130b (P<0.05), miR-181a (P<0.05) and miR-181d (P<0.01) was significantly up-regulated. The targeting efficacy of miR-130b and miR-181d was validated in vitro using dual-luciferase reporter assay system. Our results demonstrate that maternal betaine supplementation during gestation enhances GR mRNA expression in offspring hippocampus, which involves alterations in miRNAs expression.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26875838 PMCID: PMC4937150 DOI: 10.1292/jvms.15-0678
Source DB: PubMed Journal: J Vet Med Sci ISSN: 0916-7250 Impact factor: 1.267
Composition and nutrient content of the experimental diet
| Control | Betaine | |
|---|---|---|
| Ingredient, g/kg | ||
| Corn | 370 | 370 |
| Wheat | 300 | 300 |
| Bran | 80 | 80 |
| Soybean meal | 170 | 170 |
| Lignocelluloses | 30 | 30 |
| CaHPO4 | 20 | 20 |
| Soybean oil | 8 | 8 |
| Premix* | 20 | 20 |
| Betaine | 0 | 3 |
| Digestible energy, MJ/kg | 13.1 | 13.1 |
| Calculated composition | ||
| Crude protein, % | 15 | 15 |
| Crude fiber, % | 4.5 | 4.5 |
| Calcium, % | 0.84 | 0.84 |
| Phosphorous, % | 0.65 | 0.65 |
* The premix contains (per kg): vitamin A: 240,000 IU; vitamin D3: 60,000 IU; vitamin E: 720 IU; vitamin K3: 30 mg; vitamin B1: 30 mg; vitamin B2: 120 mg; vitamin B6: 60 mg; vitamin B12: 360 mg; niacin: 600 mg; pantothenic acid: 300 mg; folic acid: 6 mg; manganese sulphate: 1.0 g; zinc oxide: 2.5 g; iron sulphate: 4.0 g; copper sulphate: 4.0 g; sodium selenite: 6 mg; calcium: 150 g; phosphorus: 15 g; sodium chloride: 40 g.
Primers for real-time PCR amplification of GR mRNA and its variants, segments of GR promoter
| Target gene | Product length | Primer sequence | Reference |
|---|---|---|---|
| (bp) | (F: forward, R: reverse) | ||
| GR | 108 | F: 5’-CCAAACTCTGCCTTGTGTGTTC-3’ | AY779185 |
| R: 5’- TGTGCTGTCCTTCCACTGCT-3’ | |||
| GR 1-4 | 161 | F: 5’-CACACAGCACAACCTTTC-3’ | |
| R: 5’-AACCTTCACAGGAGTTCC-3’ | |||
| GR 1-5 | 207 | F: 5’-GCGTGCAACTTCCTTCAA-3’ | |
| R: 5’-CTTGGAGTCTGGCTGAGA-3’ | |||
| GR 1-6 | 189 | F: 5’-GAGTGGGCCGCCCAGACGAT-3’ | |
| R: 5’-CCCCCCCTCAGGCTTTTAT-3’ | |||
| GR 1-7 | 185 | F: 5’-GCGAAGAGAAACTAGAGAAA-3’ | |
| R: 5’-AACCTTCACAGGAGTTCC-3’ | |||
| GR 1-8 | 144 | F: 5’-TGCCCAGCGTCGCCAACA-3’ | |
| R: 5’-CCGCCCCTCAGGCTTTTAT-3’ | |||
| GR 1-9,10 | 177 | F: 5’-CCTGCTTTCACACGCTAA-3’ | |
| R: 5’-ATCACATGGGCTCTCTCC-3’ | |||
| GR 1-11 | 163 | F: 5’-CTGGTGGAAGTGGGCGTGTC-3’ | |
| R: 5’-TTCCTCCCCTCAGGCTTTTAT-3’ | |||
| β-actin | 201 | F: 5’-CCCACGGAATCGAGAAAGAG-3’ | AF057040 |
| R: 5’-TTGACGGAAGGGCACCA-3’ | |||
| GR segment1 | F: 5’-CGGCGAAGGTCTAGGTACG-3’ | ||
| R: 5’- GAAGGCTGCCCCGTGT-3’ | |||
| GR segment2 | F: 5’- TCTTTGAACCCCGCACTT-3’ | ||
| R: 5’- CTCCCAGCGACAAACCAG-3’ | |||
| Negative control | F: 5’- CTGGGCATCAGAACCTGT-3’ | ||
| (ACTB promoter) | R: 5’- GAGCAATCCCCTGAAGAA-3’ | ||
Primers for real-time PCR amplification of miRNAs
| Primer | Primer sequence |
|---|---|
| miR-18b | 5’-TAAGGTGCATCTAGTGCAGTTAG-3’ |
| miR-22-3p | 5’-AAGCTGCCAGTTGAAGAACTGT-3’ |
| miR-22-5p | 5’-AGTTCTTCAGTGGCAAGCTTTA-3’ |
| miR-30a-3p | 5’-CTTTCAGTCGGATGTTTGCAGC-3’ |
| miR-30a-5p | 5’-TGTAAACATCCTCGACTGGAAG-3’ |
| miR-130b | 5’-CAGTGCAATGATGAAAGGGCAT-3’ |
| miR-138 | 5’-AGCTGGTGTTGTGAATCAGGC-3’ |
| miR-181a | 5’-AACATTCAACGCTGTCGGTGAGTT-3’ |
| miR-183 | 5’-TATGGCACTGGTAGAATTCACTG-3’ |
| miR-181d | 5’-CCCACCGAGGGATGAATGTCAC-3’ |
| miR-181c | 5’-AACATTCAACCTGTCGGTGAGT-3’ |
| universal reverse primer | 5’-TAGAGTGAGTGTAGCGAGCA-3’ |
| U6 | 5’-GGCAAGGATGACACGCAAAT-3’ |
| Poly (T) adapter | 5’-TAGAGTGAGTGTAGCGAGCACAGAATTAATACG |
| ACTCACTATAGGTTTTTTTTTTTTTTTTVN-3’ |
Nucleotides sequences used in functional validation of miRNAs
| Name | Sequences (F, forward; R, reverse) | |
|---|---|---|
| miR-130b precursor | F:5’- | GATCCCCTTGGCATAACGTAGCAGCACATAATGGTTTGTGGGTTTTGAAAAGGTGCAGGCCATATTGTGCTGCCTCAAAAATACAAGGTTTTTTGGAAA-3’ |
| R:5’- | AGCTTTTCCAAAAAAGCCTGACTGATGCCCTTTCATCATTGCACTGCTTCCCAGTGGCCCACAGTAGTGCAACAGGGAAAGAGTGTCAGGCAGGCG-3’ | |
| miR-181d precursor | F:5’- | TGCTGCCCACCGAGGGATGAATGTCACGTTTTGGCCACTGACTGACGTGACATTTCCCTCGGTGGG-3’ |
| R:5’- | CCTGCCCACCGAGGGAAATGTCACGTCAGTCAGTGGCCAAAACGTGACATTCATCCCTCGGTGGGC-3’ | |
| miR-SC | F:5’- | GATCCGACTTACAGCCAGTTCCTAGTATAGTGAAGCAGCAGATGGTATACTAGGAACTGGCTGTAAGCTTTTTTTGGAAA-3’ |
| R:5’- | AGCTTTTCCAAAAAAAGCTTACAGCCAGTTCCTAGTATACCATCTGCTGCTTCACTATACTAGGAACTGGCTGTAAGTCG-3’ | |
| GR 3’UTR primer | F:5’- | TCTAGACTTTCGTTGGTGTAT-3’ |
| R:5’- | TCTAGAGCAAACCCATTGGG-3’ |
Fig. 3.(A) Plasmid structure containing miR-130b and miR-181d and control sequences. Cloning region is indicated in dot line with respective miRNAs and control sequence. Original structure of pSilencerTM 3.1-H1 neo is cited from manual of the Kit. (B) Plasmid structure containing GR 3’UTR sequences. Cloning region is indicated in dot line with GR 3’UTR sequences (1,384 bp). Original structure of pGL3-Control Vector is cited from manual of the Kit. (C) Statistic results of the data from dual luciferase activity assay system. Values are means, with their standard errors. *and ** indicate significant difference between groups at P<0.05 and P<0.01, respectively.
Fig. 1.RT-PCR demonstrated that hippocampal expression of GR exon 1-4 and 1-9,10 mRNA was higher in betaine-treated group, associated with the higher total GR mRNA. Meanwhile, western blotting analysis showed that total GR protein content was not changed so much. Values are means, with their standard errors, and * indicates significant difference between groups at P<0.05, ** means at P<0.01.
Fig. 2.CpG sites are underlined in detectable segment1 (–4861 ~ –4722) and segment2 (–1650 ~ –1515) from translation start codon (ATG), which were marked as block in GR exon 1 structure diagram (blank arrow). Predicted transcription factor binding sites among segment2 were framed. MeDIP results are presented in column figure, showing DNA methylation status of CpGs in segment2 was increased. Values are means, with their standard errors, and * indicates significant difference between groups at P<0.05.
Expression of miRNAs targeting porcine GR 3’UTR
| Predicted miRNAs | Control (n = 5) | Betaine (n = 5) | |
|---|---|---|---|
| miR-130b | 1.00 ± 0.09 | 1.35 ± 0.09 | 0.03 |
| miR-138 | 1.00 ± 0.06 | 1.10 ± 0.06 | 0.26 |
| miR-18b | 1.00 ± 0.09 | 1.09 ± 0.10 | 0.50 |
| miR-181a | 1.00 ± 0.06 | 1.22 ± 0.06 | 0.04 |
| miR-181c | 1.00 ± 0.08 | 1.07 ± 0.09 | 0.61 |
| miR-181d | 1.00 ± 0.41 | 3.08 ± 0.14 | 0.00 |
| miR-183 | 1.00 ± 0.13 | 1.29 ± 0.14 | 0.16 |
| miR-22-3p | 1.00 ± 0.06 | 1.07 ± 0.09 | 0.51 |
| miR-22-5p | 1.00 ± 0.10 | 1.10 ± 0.11 | 0.54 |
| miR-30a-3p | 1.00 ± 0.09 | 1.04 ± 0.05 | 0.71 |
| miR-30a-5p | 1.00 ± 0.07 | 1.12 ± 0.06 | 0.26 |
Mean values with their standard errors.